Despite FDA’s labeling of tagatose as an added sugar, the alternative sweetener’s nutritional and functional benefits continue to generate interest from the food and beverage industry, particularly with lean labels, Jim Kappas, VP specialty ingredients,...
European industrial biotechnology specialist BRAIN Biotech has teamed up with Bonumose to bring the rare sugars expert’s sweetener tagatose to market globally.
Bonumose – a Virginia-based startup with patented technology it claims could enable the mass market adoption of rare sugars which have exciting benefits but currently come with a hefty price tag – is gearing up to start commercial production of tagatose...
The FDA has denied a request to exempt rare sugar tagatose from the total and added sugars declaration on the Nutrition Facts panel, three years after granting the same request for rare sugar allulose, a decision petitioner Bonumose has slammed as “contradictory...
Bonumose – a Virginia-based startup with patented technology it claims could enable the mass market adoption of rare sugars such as allulose and tagatose – is investing $27.7m in production and R&D facilities in a 36,000 sq ft facility in Pantops,...
Leading CPG companies including Unilever, Hershey, and General Mills have urged the FDA to look again at the way some sugars such as tagatose and isomaltulose are labeled on the Nutrition Facts panel in the wake of recent changes to the way allulose is...
Bonumose – a Virginia-based startup with patented technology it claims could enable the “mass market adoption” of rare sugars – has raised a Series B* round led by Hershey and sugar refining giant ASR Group, to support commercial production of allulose...